A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Phase 2

Completed

• Conditions: Open-Angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00372931
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05
• Study First Submitted: 2006-09-06
• Study First Submitted QC: 2006-09-06
• Study First Posted: 2006-09-07
• Primary Completion: 2007-08
• Status Verified: 2008-04
• Last Update Submitted: 2008-04-21
• Last Update Posted: 2008-04-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Adult patients of either sex and any race with open-angle glaucoma or ocular hypertension; logMAR visual acuity not worse than 0.60; additionally clinically relevant ophthalmic or systemic conditions may be excluded

Exclusion Criteria

• Under 18

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean IOP change from baseline

Trial Locations

Locations (1)

San Antonio Site; 🇺🇸 San Antonio, Texas, United States